Safety, Tolerability, and Pharmacokinetics of a Novel Mitochondrial Modulator, TRC150094, in Overweight and Obese Subjects: A Randomized Phase-I Clinical Trial

• Asıl Yazarlar: Deepa Joshi (Yazar), Prashant Jamadarkhana (Yazar), Suchit Kumbhare (Yazar), Amarinder Singh (Yazar), Jignesh Kotecha (Yazar), Deepak Bunger (Yazar), Ajay Shiwalkar (Yazar), Anookh Mohanan (Yazar), Chaitanya Dutt (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

TRC150094, a novel mitochondrial modulator, can restore metabolic flexibility by improving insulin resistance in preclinical studies. This study primarily aims to evaluate the safety, tolerability, and pharmacokinetics (PK) of oral TRC150094 after conducting two double-blind, randomized, Phase-I stu...